Evidence map›Paper›PMID 38987330›Full record

ArticleScientific reports2024

Hyperosmotic sisomicin infusion: a mouse model for hearing loss.

Ayse Maraslioglu-Sperber, Fabian Blanc, Stefan Heller, Nesrine Benkafadar

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Ayse Maraslioglu-Sperber *Department of Otolaryngology - Head & Neck Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Fabian Blanc *Department of Otolaryngology - Head & Neck Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Stefan HellerDepartment of Otolaryngology - Head & Neck Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Nesrine BenkafadarDepartment of Otolaryngology - Head & Neck Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA. kafadar@stanford.edu.

Funding

Regenerative pathways in the avian cochleaR01DC019619 · NIDCD · STANFORD UNIVERSITY · PI Stefan Heller · 2022 to 2026
$3.2M
Avian-inspired Regenerative Therapies for Hearing LossR21DC021755 · NIDCD · STANFORD UNIVERSITY · PI Nesrine Benkafadar · 2024 to 2026
$579k
NIDCD NIH HHS R01 DC019619NIDCD NIH HHS R21 DC021755NIH HHS R01-DC019619
6 · The paper itself

Abstract

Losing either type of cochlear sensory hair cells leads to hearing impairment. Inner hair cells act as primary mechanoelectrical transducers, while outer hair cells enhance sound-induced vibrations within the organ of Corti. Established inner ear damage models, such as systemic administration of ototoxic aminoglycosides, yield inconsistent and variable hair cell death in mice. Overcoming this limitation, we developed a method involving surgical delivery of a hyperosmotic sisomicin solution into the posterior semicircular canal of adult mice. This procedure induced rapid and synchronous apoptotic demise of outer hair cells within 14 h, leading to irreversible hearing loss. The combination of sisomicin and hyperosmotic stress caused consistent and synergistic ototoxic damage. Inner hair cells remained until three days post-treatment, after which deterioration in structure and number was observed, culminating in a complete hair cell loss by day seven. This robust animal model provides a valuable tool for otoregenerative research, facilitating single-cell and omics-based studies toward exploring preclinical therapeutic strategies.

Indexed as

Disease Models, AnimalHearing LossAminoglycosidesAnimalsApoptosisHair Cells, Auditory, InnerHair Cells, Auditory, OuterMiceOsmotic PressureAminoglycosidesCochleaHair cellHearing lossSisomicinSupporting cell

Identifiers

PMID38987330
PMCPMC11237112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.